NCT04183062 2024-11-08
BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung Metastases
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
Phase 2 Withdrawn
Clinical Trials
21 trialsNCT05512182 2023-06-15
Efficacy of Triplet Combination With Pembrolizumab, Neratinib, and Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer Having Somatic Human Epidermal Growth Factor Receptor Family (EGFR, HER2, HER3, HER4) Mutations or HER2 Amplification/Overexpression
Yonsei University
Phase 2 Withdrawn
NCT03982537 2022-12-19
Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT05481775 2022-11-21
Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer
Sun Yat-sen University
Phase 2 Withdrawn
NCT05245760 2022-11-08
CRATER
University of Kentucky
Phase 2 Withdrawn
NCT04420130 2022-10-04
A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）
Harbin Medical University
Phase NA Withdrawn
NCT03199144 2022-06-23
CKPancreas
Centre Francois Baclesse, Luxembourg
Phase 2 Withdrawn
NCT04795596 2022-04-15
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers
Menoufia University
Phase 2/3 Withdrawn
NCT03628144 2020-09-10
Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn
NCT03532204 2019-05-22
OLIVER
UNICANCER
Phase NA Withdrawn
NCT01811810 2019-04-23
Proton Therapy for High Risk Prostate Cancer
Abramson Cancer Center at Penn Medicine
Phase NA Withdrawn
NCT01796444 2018-04-05
Z0011-China
Shandong Cancer Hospital and Institute
Phase 3 Withdrawn
NCT01531751 2018-03-21
DIACAL
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 2 Withdrawn
NCT02425072 2017-08-10
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Phase 2 Withdrawn
NCT02539017 2016-08-10
The Clinical Significance of Cellular Immune Adjuvant Therapy of Triple Negative Breast Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase 2 Withdrawn
NCT02376413 2015-12-03
Oncoplastic Breast-conserving Surgery in Non-metastatic Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Withdrawn
NCT00985998 2015-08-19
Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer
Biotech Pharmaceutical Co., Ltd.
Phase 1 Withdrawn
NCT00873600 2015-03-19
Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer
Case Comprehensive Cancer Center
Withdrawn
NCT01533727 2013-12-09
CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)
Sun Yat-sen University
Phase 2 Withdrawn
NCT00403182 2012-06-01
Chemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast Cancer
Technical University of Munich
Phase 3 Withdrawn
NCT00005969 2012-02-20
Liposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's Disease
M.D. Anderson Cancer Center
Phase 2 Withdrawn